What makes interpreting the evidence so complicated and how does this affect patients?
©Sang Tan and Wix
Approximately 1 in 6 couples worldwide suffer from infertility and the IVF industry has been one of the fastest growing medical industries of the 21st century, estimed to reach a market size exceeding $36 billion by 2026! Treatment is also often accessed through the private sector, leading to competition between clinics and provision of so-called 'add on' services, including complementary therapies such as acupuncture - often with limited evidence but a high price tag.
In her talk on 14th of December, Julia will explain why gathering evidence for complementary treatments using traditional scientific methods is challenging and the issues this poses to patients accessing fertility treatment.
Presenter Info
Julia Stein, 14th of December Speaker
Julia graduated from the Rellu IB diploma programme in 2016 and has since studied Medical Sciences at the University of Edinburgh (BSc with Honours) and completed a Master of Research (MRes) degree in Reproductive Science and Women's Health at University College London. For her postgraduate thesis, she explored the evidence for and provision of complementary therapies during in vitro fertilisation (IVF) treatment. Her research has been published and presented at the 2021 annual conference of the European of Human Reproduction and Embryology. She currently works as a researcher for a healthcare consultancy company specialising in clinical trial outcome measurement strategies.
©Unsplash